UGT1A3 (UDP glucuronosyltransferase family 1 member A3)

2016-01-01  

Identity

HGNC
LOCATION
2q37.1
LOCUSID
ALIAS
UDPGT,UDPGT

Other Information

Locus ID:

NCBI: 54659
MIM: 606428
HGNC: 12535
Ensembl: ENSG00000243135

Variants:

dbSNP: 54659
ClinVar: 54659
TCGA: ENSG00000243135
COSMIC: UGT1A3

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000243135ENST00000482026P35503
ENSG00000243135ENST00000482026Q5DT01

Expression (GTEx)

0
1
2

Pathways

PathwaySourceExternal ID
Pentose and glucuronate interconversionsKEGGko00040
Ascorbate and aldarate metabolismKEGGko00053
Steroid hormone biosynthesisKEGGko00140
Retinol metabolismKEGGko00830
Porphyrin and chlorophyll metabolismKEGGko00860
Metabolism of xenobiotics by cytochrome P450KEGGko00980
Drug metabolism - cytochrome P450KEGGko00982
Drug metabolism - other enzymesKEGGko00983
Pentose and glucuronate interconversionsKEGGhsa00040
Ascorbate and aldarate metabolismKEGGhsa00053
Steroid hormone biosynthesisKEGGhsa00140
Retinol metabolismKEGGhsa00830
Porphyrin and chlorophyll metabolismKEGGhsa00860
Metabolism of xenobiotics by cytochrome P450KEGGhsa00980
Drug metabolism - cytochrome P450KEGGhsa00982
Drug metabolism - other enzymesKEGGhsa00983
Metabolic pathwaysKEGGhsa01100
Glucuronate pathway (uronate pathway)KEGGM00014
Chemical carcinogenesisKEGGhsa05204
Chemical carcinogenesisKEGGko05204
Glucuronate pathway (uronate pathway)KEGGhsa_M00014
MetabolismREACTOMER-HSA-1430728
Biological oxidationsREACTOMER-HSA-211859
Phase II conjugationREACTOMER-HSA-156580
GlucuronidationREACTOMER-HSA-156588

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA10251atazanavirChemicalClinicalAnnotationassociatedPD17058217
PA133950441hmg coa reductase inhibitorsChemicalPathwayassociated
PA164760843deferasiroxChemicalClinicalAnnotationassociatedPKPD27043265, 27193993, 28346059, 30651574
PA165110775SN-38ChemicalPathwayassociated
PA165958521febuxostatChemicalClinicalAnnotationassociatedPD27798726
PA166123367gepirone hydrochlorideChemicalVariantAnnotationnot associatedPK25192553
PA420UGT1A1GeneVipGeneassociated15179404, 18004212, 18491077, 18518849, 19794410, 19997083, 8467709, 11434514
PA443450AsthmaDiseaseClinicalAnnotation, VariantAnnotationambiguousPK25192553, 28940478
PA444065EpilepsyDiseaseClinicalAnnotationassociatedPK28763744
PA444318GoutDiseaseClinicalAnnotationassociatedPD27798726
PA444511HyperbilirubinemiaDiseaseClinicalAnnotationassociatedPD17058217
PA445601OsteosarcomaDiseaseClinicalAnnotationassociatedPK29791011
PA446432beta-ThalassemiaDiseaseClinicalAnnotationassociatedPKPD27043265, 27193993, 28346059, 30651574
PA447216SchizophreniaDiseaseClinicalAnnotationassociatedPD
PA447230HIVDiseaseClinicalAnnotationassociatedPD17058217
PA448320allopurinolChemicalClinicalAnnotationassociatedPD27798726
PA448500atorvastatinChemicalClinicalAnnotation, Pathway, VariantAnnotationassociatedPKPD22555810
PA449688fluvastatinChemicalPathwayassociated
PA449957ibuprofenChemicalPathwayassociated25502615
PA450272lovastatinChemicalPathwayassociated
PA450428methotrexateChemicalClinicalAnnotationassociatedPK29791011
PA450546montelukastChemicalClinicalAnnotation, VariantAnnotationassociatedPK28940478
PA451257risperidoneChemicalClinicalAnnotationassociatedPD
PA451260ritonavirChemicalClinicalAnnotationassociatedPD17058217
PA451363simvastatinChemicalPathwayassociated
PA451846valproic acidChemicalClinicalAnnotationassociatedPK28763744
PA451899vitamin d and analoguesChemicalLiterature, MultilinkAnnotationassociated24641623

References

Pubmed IDYearTitleCitations
344806022022Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.1
344806022022Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolites.1
336586282021Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing.5
336586282021Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing.5
324981192020UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics-A Comprehensive Pharmacogenomic Study.7
324981192020UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics-A Comprehensive Pharmacogenomic Study.7
308894882019Combination of hesperetin and platinum enhances anticancer effect on lung adenocarcinoma.13
308894882019Combination of hesperetin and platinum enhances anticancer effect on lung adenocarcinoma.13
284437232018Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes.15
284437232018Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes.15
257438472015Increased UGT1A3 and UGT1A7 expression is associated with pancreatic cancer.8
257438472015Increased UGT1A3 and UGT1A7 expression is associated with pancreatic cancer.8
246416232014Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability.25
246416232014Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability.25
236118092013Human UDP-glucuronosyltransferase (UGT) 2B10 in drug N-glucuronidation: substrate screening and comparison with UGT1A3 and UGT1A4.13

Citation

Dessen P

UGT1A3 (UDP glucuronosyltransferase family 1 member A3)

Atlas Genet Cytogenet Oncol Haematol. 2016-01-01

Online version: http://atlasgeneticsoncology.org/gene/55580/favicon/js/lib/popper.js